AG0037YF

112529-15-4 | 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride

AG0037YF

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	112529-15-4
Catalog Number	AG0037YF(AGN-PC-09RABZ)
Chemical Name	5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride
IUPAC Name	5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride
InChI	InChI=1S/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H
InChI Key	GHUUBYQTCDQWRA-UHFFFAOYSA-N
MDL Number	MFCD04975446
Molecular Formula	C19H21ClN2O3S
Molecular Weight	392.8996
SMILES	Cl.C(C)C=1C=CC(=NC1)CCOC1=CC=C(CC2C(NC(S2)=O)=O)C=C1
Synonyms	5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione, Actos, AD 4833, AD-4833, AD4833, pioglitazone, Poglitazone Hydrochloride, U 72107A, U-72107A, U72,107A, U72107A, pioglitazone hydrochloride, 112529-15-4, Pioglitazone HCl, Pioglitazone (hydrochloride), 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride, U-72107A, Pioditazone hydrochloride, MFCD04975446, AD 4833, [5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride, NCGC00095131-01, U-72107E, Actos (TN), (+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride, DSSTox_CID_24203, DSSTox_RID_80116, C19H21ClN2O3S, DSSTox_GSID_44203, U 72107A, Piomed, 5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione HCl, 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride, 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione hydrochloride, 2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)-, 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, monohydrochloride, SMR000469167, CAS-112529-15-4, U-72107, 5-(4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl)thiazolidine-2,4-dione hydrochloride, 5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hcl, 5-(4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl)-thiazolidine-2,4-dione hydrochloride, 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride, 5-[4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-benzyl]-thiazolidine-2,4-dione hydrochloride, 5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione hydrochloride, Pioglitazone hydrochloride [USAN], 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione hydrochloride, 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride, Pioglitazone hydrochloride [USAN:USP], AC1L1THE, pioglitazone, hydrochloride, AC1Q6GK5, CHEMBL1715, SCHEMBL21843, C19H20N2O3S.HCl, MLS001306462, MLS001401386, SPECTRUM1504401, pioglitazone-hydrochloride-actos, CHEBI:8229, DTXSID3044203, Pioglitazone Hydrochloride ,(S), CTK8B3228, GHUUBYQTCDQWRA-UHFFFAOYSA-N, HMS1922L05, Pioglitazone hydrochloride (Actos), ACT04238, BCP22942, KS-00000IO7, Tox21_111440, Tox21_300584, ANW-42027, CCG-39097, CP0139, s2046, AKOS015844016, Tox21_111440_1, AC-1037, CCG-100931, CS-2235, KS-1186, MCULE-1259842295, NC00181, Pioglitazone hydrochloride (JP17/USP), RTR-001112, SB17324, NCGC00095131-02, NCGC00163128-08, NCGC00254492-01, AA-10090, AK-50391, AN-15335, BC204340, BR-50391, CPD000469167, HY-14601, I868, SAM001246600, SC-19064, BCP0726000151, AB0013914, AB1009260, LS-151328, LS-172192, Pioglitazone hydrochloride, >=98% (HPLC), ST2411660, TL8000362, TR-001112, AM20061770, FT-0082357, FT-0601607, P1901, SW197561-4, A-2403, D00945, J10107, 025P468, A802593, I06-0413, Q-201584, Pioglitazone hydrochloride, European Pharmacopoeia (EP) Reference Standard, [(+-)-5-[[4-[4-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] monohydrochloride, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, hcl, 5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, hydrochloride, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride, 5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride, 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride, 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione hydrochloride, Pioglitazone for system suitability, European Pharmacopoeia (EP) Reference Standard, Pioglitazone hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Pioglitazone hydrochloride, United States Pharmacopeia (USP) Reference Standard, 2,4-thiazolidinedione,5-((4-(2-(5-ehtyl-2-pyridinyl)ethoxy)phenyl)methyl)-monohydrochloride, Actos, Pioglitazone, Duetact, Glustin, Zactos, Mixture Name, UNII-JQT35NPK6C, JQT35NPK6C, C19H20N2O3S.ClH, AD-4833, CID60560, C19-H20-N2-O3-S.Cl-H, ACN-043963, CS-O-11717, Pioglitazone hydrochloride, 98% 250mg, A4324, 112529-15-4 (HCl), 111025-46-8, (5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-) thiazolidinedione hydrochloride, Pioglitazone hydrochloride, 99%, a receptor-gamma (PPARgamma) agonist - 25G 25g,

Complexity	466
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	392.096g/mol
Formal Charge	0
Heavy Atom Count	26
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	392.898g/mol
Monoisotopic Mass	392.096g/mol
Rotatable Bond Count	7
Topological Polar Surface Area	93.6A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H319
Packing Group
Precautionary statements	P305+P351+P338
UN Code

Certificate of Analysis

Lot Number